Drug delivery systems using mesoporous oxide films

Details Drug delivery systems using mesoporous oxide films Drug delivery systems using mesoporous oxide films

2011-07-19

2011-07-19

Azpuru, Carlos (Department: 1617)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

Reexamination Certificate

active

07981441

ABSTRACT:
Sustained-release drug-delivery devices employing a mesoporous oxide coating that functions as a drug reservoir, and the use of mesoporous oxide coatings for improved adhesion of organic polymers to inorganic substrates.

REFERENCES:
patent: 5057296 (1991-10-01), Beck
patent: 5102643 (1992-04-01), Kresge et al.
patent: 5516781 (1996-05-01), Morris et al.
patent: 5622684 (1997-04-01), Pinnavaia et al.
patent: 6054111 (2000-04-01), Antonietti et al.
patent: 6318124 (2001-11-01), Rutherford et al.
patent: 6334988 (2002-01-01), Gallis et al.
patent: 6365266 (2002-04-01), MacDougall et al.
patent: 6395299 (2002-05-01), Babich et al.
patent: 6458310 (2002-10-01), Liu
patent: 6465365 (2002-10-01), Annapragada
patent: 6511658 (2003-01-01), Mattai et al.
patent: 6541539 (2003-04-01), Yang et al.
patent: 6592764 (2003-07-01), Stucky et al.
patent: 6592980 (2003-07-01), MacDougall et al.
patent: 6592991 (2003-07-01), Weisner et al.
patent: 6730064 (2004-05-01), Ragheb et al.
patent: 6991802 (2006-01-01), Ahola et al.
patent: 2002/0164380 (2002-11-01), Ma et al.
patent: 2008/0234810 (2008-09-01), Carlson et al.
patent: 0872447 (1998-10-01), None
patent: 98/34723 (1998-08-01), None
patent: 99/36357 (1999-07-01), None
patent: 99/47570 (1999-09-01), None
patent: 00/66190 (2000-04-01), None
patent: 00/25841 (2000-05-01), None
patent: 00/29501 (2000-05-01), None
patent: 01/28529 (2001-04-01), None
patent: 02/058775 (2002-08-01), None
patent: 03/055534 (2003-07-01), None
patent: 2005/000740 (2005-01-01), None
Kortesuo, P., “Sol-Gel Derived Silica Gel Monoliths and Microparticles as Carrier in controlled Drug Delivery in Tissue Administration”, Academic Dissertation, University of Helsinki, 2001, pp. 1-41.
Beck JS, et al., “A new family of mesoporous molecular sieves prepared with liquid crystal templates.” J. Am. Chem. Soc, 1992, 114:10834-10843.
Brinker CJ, et al., “Evaporation-induced self-assembly: nanostrucutres made easy.” Advanced Materials, 1999, 11 (7):579-585.
Kresge CT, et al., “Ordered mesoporous molecular sieves synthesized by a liquid crystal template mechanism.” Nature, Oct. 1992, 359:710-712.
Vallet-Regi M, et al., “A new property of MCM-41: drug delivery system.” Chem. Mater., 2001, 13:308-311.
Munoz B, et al., “MCM-41 organic modification as drug delivery rate regulator.” Chem. Mater., 2003, 15:500-503.
Schmidt-Winkel P, et al., “Microemulsion templating of siliceous mesostructured cellular foams with well-defined ultralarge mesopores.” Chem. Mater., 2000, 12:686-696.
Khushalani D, et al., “Metamorphic materials: restructuring siliceous mesoporous materials.” Advanced Materials, 1995, 7:842-846.
Galarneau A, et al., “Microporosity and connections between pores in SBA-15 mesotructured silicas as a function of the temperature of synthesis.” New J. Chem., 2003, 27:73-79.
Xia Y, et al., “Soft lithography.” Angew. Chem. Intl. Ed., 1998, 37:550-575.
Trau M, et al., “Miroscopic patterning of orientated mesoscopic silica through guided growth.” Nature, 1997, 390:674-676.
Holland BT, et al., “Synthesis of macroporous minerals with highly ordered three-dimensional arrays of spheroidal voids.” Science, 1998, 281:538-540.
Imhof A, et al., “Ordered macroporous materials by emulsion templating.” Nature, 1997, 389:948-951.
Yang P, et al., “Hierarchically ordered oxides.” Science, 1998, 282:2244-6.
Schuth, In: Studies in Surface Science and Catalysis, Galarneau A, et al (eds.), Proceedings of the 13th Internaltional Zeolite Conference, Montpellier, France, 2001, 135:1-12.
Doadrio AL, et al., “Mesoporous SBA-15 HPLC evaluation for controlled genamicin drug delivery.” Journal of Controlled Release, 2004, 97(1):125-132.
Mal NK, et al., “Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica.” Nature, Jan. 2003, 242:350-353.
Axel DI, et al., “Paclitaxel inhibits arterial smooth muscle proliferation and migration in vitro and in vivo using local drug delivery.” Circulation, 1997, 96:636-645.
Drachman DE, et al., “Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months.” J. Am. Coll. Cardiol., 2000, 36:2325-2332.
Grube E, et al., “High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial.” J. Am. Coll. Cardiol., 2004, 44:1368-72.
Kortesuo P, “Sol-gel-processed sintered silica xerogel as a carrier in controlled drug delivery.” Journal of Biomedical Materials Research, 1999, 44:162-7.
Heldman AW, et al., “Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.” Circulation, 2001, 103:2289-2295.
Dauskardt RH, et al., “Adhesion and debonding of multi-layer thin film structures.” Engineering Fracture Mechanics, 1998, 61:141-162.

Affiliated with

Also associated with

Rating

Drug delivery systems using mesoporous oxide films does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug delivery systems using mesoporous oxide films, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug delivery systems using mesoporous oxide films will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2736159